These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2196303)

  • 21. Systemic allergy to human (recombinant DNA) insulin.
    Gossain VV; Rovner DR; Mohan K
    Ann Allergy; 1985 Aug; 55(2):116-8. PubMed ID: 3896050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of long-term exposure to insulin lispro on the induction of antibody response in patients with type 1 or type 2 diabetes.
    Fineberg SE; Huang J; Brunelle R; Gulliya KS; Anderson JH
    Diabetes Care; 2003 Jan; 26(1):89-96. PubMed ID: 12502663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human insulin analog insulin aspart does not cause insulin allergy.
    Yasuda H; Nagata M; Moriyama H; Fujihira K; Kotani R; Yamada K; Ueda H; Yokono K
    Diabetes Care; 2001 Nov; 24(11):2008-9. PubMed ID: 11679481
    [No Abstract]   [Full Text] [Related]  

  • 24. Antibody-Mediated Extreme Insulin Resistance: A Report of Three Cases.
    Kim HN; Fesseha B; Anzaldi L; Tsao A; Galiatsatos P; Sidhaye A
    Am J Med; 2018 Jan; 131(1):102-106. PubMed ID: 28822702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human insulin.
    Larkins RG
    Aust N Z J Med; 1983 Dec; 13(6):647-51. PubMed ID: 6372774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IgE and IgG antibody against human (recombinant DNA) insulin in patients with systemic insulin allergy.
    Grammer LC; Roberts M; Patterson R
    J Lab Clin Med; 1985 Jan; 105(1):108-13. PubMed ID: 3881543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generalized allergy due to zinc in insulin treated with zinc-free insulin.
    Ben Ammar I; Ksouri H; Trabelsi N; Mellouli F; Ben Mami F; Dakhli S; Achour A
    Acta Diabetol; 2012 Jun; 49(3):239-41. PubMed ID: 20963448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin allergy: reaginic antibodies to insulin and proinsulin.
    Kumar D; Rosenquist RJ; Parameswaran V
    J Clin Endocrinol Metab; 1979 Aug; 49(2):252-4. PubMed ID: 457844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin antibodies and hypoglycemia in diabetic patients. Can a quantitative analysis of antibody binding predict the risk of hypoglycemia?
    Kim MR; Sheeler LR; Mansharamani N; Haug MT; Faiman C; Gupta MK
    Endocrine; 1997 Jun; 6(3):285-91. PubMed ID: 9368685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Affinity of IgG-insulin antibodies to human (recombinant DNA) insulin and porcine insulin in insulin-treated diabetic individuals with and without insulin resistance.
    Schernthaner G
    Diabetes Care; 1982; 5 Suppl 2():114-8. PubMed ID: 6765520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specificity of IgE antibody against various insulins in a patient with anaphylaxis to beef-pork insulin but not to human (rDNA) insulin.
    Grammer LC; Roberts M
    Clin Exp Allergy; 1989 Sep; 19(5):551-3. PubMed ID: 2790563
    [No Abstract]   [Full Text] [Related]  

  • 32. Lymphocyte proliferation as a test of the immune response to insulin in diabetics.
    Kurtz AB; Di Silvio L; Lydyard P
    Diabetes Res; 1985 Jul; 2(4):175-8. PubMed ID: 3910325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of biosynthetic human insulin and purified pork insulin. Studies in insulin-resistant obese patients using the insulin suppression test].
    Richard JL; Rodier M; Cavalie G; Lachkar H; Orsetti A; Monnier L; Mirouze J
    Diabete Metab; 1986 Feb; 12(1):6-9. PubMed ID: 2870943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin allergy treated with human insulin (recombinant DNA).
    De Leeuw I; Delvigne C; Bekaert J
    Diabetes Care; 1982; 5 Suppl 2():168-70. PubMed ID: 6765530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Desensitization for insulin allergy: a useful treatment also for local forms.
    Eguíluz-Gracia I; Rodríguez-Alvarez M; Cimarra-Alvarez M; Sanabria-Pérez MC; Martínez-Cócera C
    J Investig Allergol Clin Immunol; 2012; 22(3):215-6. PubMed ID: 22697012
    [No Abstract]   [Full Text] [Related]  

  • 36. Severe insulin allergy successfully treated with continuous subcutaneous insulin infusion.
    Fujikawa T; Imbe H; Date M; Go Y; Kitaoka H
    Diabetes Res Clin Pract; 2012 Aug; 97(2):e31-3. PubMed ID: 22609054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immediate-type human insulin allergy successfully treated by continuous subcutaneous insulin infusion.
    Nagai T; Nagai Y; Tomizawa T; Mori M
    Intern Med; 1997 Aug; 36(8):575-8. PubMed ID: 9260776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological resistance to human biosynthetic insulin--effects of immunosuppression and plasmapheresis.
    Micić D; Brkić S; Kendereski A; Popović V; Zorić S; Nikolić JA; Igrutinović L; Ivanoska D; Manojlović D; Micić J
    Diabetes Res Clin Pract; 1993 Jan; 19(1):83-9. PubMed ID: 8472623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The immunogenicity of new insulins.
    Deckert T
    Diabetes; 1985 Jun; 34 Suppl 2():94-6. PubMed ID: 3888748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Desensitization with human (recombinant DNA) insulin.
    Bodendorfer TW; Brown ME; Frankel EH; Palay BH; Fulp SR
    Drug Intell Clin Pharm; 1985 Nov; 19(11):827-9. PubMed ID: 3905321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.